{"id":"bleomycin-sulfate-blm","safety":{"commonSideEffects":[{"rate":"1-10","effect":"Pulmonary fibrosis"},{"rate":"30-40","effect":"Myelosuppression"},{"rate":"20-30","effect":"Mucositis"},{"rate":"20-30","effect":"Alopecia"},{"rate":"30-40","effect":"Nausea and vomiting"},{"rate":"10-20","effect":"Skin toxicity/hyperpigmentation"},{"rate":"20-25","effect":"Fever"}]},"_chembl":{"chemblId":"CHEMBL6067493","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Bleomycin intercalates into DNA and forms complexes with metal ions (particularly iron and copper) that generate reactive oxygen species and cause double-strand breaks. This results in inhibition of DNA synthesis and cell division, making it effective against rapidly dividing cancer cells. It is used primarily in combination chemotherapy regimens for various malignancies.","oneSentence":"Bleomycin is a chemotherapeutic antibiotic that binds to DNA and causes strand breaks, leading to cell death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:04:29.596Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hodgkin lymphoma"},{"name":"Non-Hodgkin lymphoma"},{"name":"Testicular cancer"},{"name":"Squamous cell carcinoma of the head and neck"},{"name":"Cervical cancer"},{"name":"Ovarian cancer"}]},"trialDetails":[{"nctId":"NCT02166463","phase":"PHASE3","title":"Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-03-19","conditions":"Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma","enrollment":600},{"nctId":"NCT04281290","phase":"NA","title":"Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2020-07-13","conditions":"Pancreas Cancer","enrollment":10},{"nctId":"NCT07498959","phase":"NA","title":"Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer","status":"RECRUITING","sponsor":"Sahlgrenska University Hospital","startDate":"2026-03-19","conditions":"Testicular Cancer, Seminoma, Quality of Life","enrollment":160},{"nctId":"NCT05675410","phase":"PHASE3","title":"A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-05-11","conditions":"Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8","enrollment":1875},{"nctId":"NCT07443475","phase":"PHASE2","title":"Electrochemotherapy for Recurrent Vulvar Cancer","status":"RECRUITING","sponsor":"Institute of Oncology Ljubljana","startDate":"2021-09-01","conditions":"Vulvar Cancer, Recurrent Vulvar Cancer","enrollment":13},{"nctId":"NCT01712490","phase":"PHASE3","title":"A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Takeda","startDate":"2012-11-09","conditions":"Hodgkin Lymphoma","enrollment":1334},{"nctId":"NCT03067181","phase":"PHASE3","title":"Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2017-05-25","conditions":"Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma, Germ Cell Tumor","enrollment":1780},{"nctId":"NCT03755804","phase":"PHASE2","title":"Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2018-12-12","conditions":"Hodgkin Lymphoma","enrollment":232},{"nctId":"NCT03407144","phase":"PHASE2","title":"Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-04-09","conditions":"Hodgkin Lymphoma","enrollment":340},{"nctId":"NCT06388252","phase":"NA","title":"Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Institute of Oncology Ljubljana","startDate":"2023-11-10","conditions":"Cutaneous Malignant Melanoma","enrollment":10},{"nctId":"NCT07404605","phase":"NA","title":"Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma","status":"RECRUITING","sponsor":"Institute of Oncology Ljubljana","startDate":"2023-09-01","conditions":"MELANOMA, SKIN NEOPLASMS","enrollment":150},{"nctId":"NCT04685616","phase":"PHASE3","title":"Brentuximab Vedotin in Early Stage Hodgkin Lymphoma","status":"RECRUITING","sponsor":"University College, London","startDate":"2022-04-14","conditions":"Hodgkin Lymphoma","enrollment":1042},{"nctId":"NCT03033914","phase":"PHASE1, PHASE2","title":"A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2017-01-25","conditions":"Hodgkin Lymphoma","enrollment":82},{"nctId":"NCT03596918","phase":"","title":"Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine","status":"COMPLETED","sponsor":"AIDS Malignancy Consortium","startDate":"2018-10-10","conditions":"AIDS-Related Kaposi Sarcoma, Human Immunodeficiency Virus 1 Positive","enrollment":10},{"nctId":"NCT06480773","phase":"","title":"Kaposi Sarcoma Chemotherapy and Research (KS-CARE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2023-04-25","conditions":"Kaposi Sarcoma, HIV","enrollment":127},{"nctId":"NCT06911177","phase":"NA","title":"Yeast Mannans and Stool Frequency","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-07-17","conditions":"Defecation Frequency","enrollment":70},{"nctId":"NCT07378657","phase":"PHASE3","title":"Systematic Approach for Children With Orbital Malformation With Sirolimus Use","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-11-01","conditions":"Orbital Lymphatic Malformation","enrollment":30},{"nctId":"NCT07320430","phase":"NA","title":"Comparative Study Between Sclerosing Agents Used in Treatment of Vascular Malformation","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-02-14","conditions":"Vascular Malformation","enrollment":75},{"nctId":"NCT07320001","phase":"PHASE2","title":"Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations","status":"NOT_YET_RECRUITING","sponsor":"Basharat Hussain","startDate":"2026-01-26","conditions":"Lymphatic Abnormality","enrollment":92},{"nctId":"NCT06660121","phase":"","title":"Electrochemotherapy for Desmoid Tumors","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2024-10-17","conditions":"Desmoid Fibromatosis","enrollment":30},{"nctId":"NCT03199300","phase":"","title":"Investigating Cardiovascular Adverse Events Related to Cancer Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2017-12-12","conditions":"Toxicity Due to Chemotherapy, Cardiovascular Morbidity, Cancer, Treatment-Related","enrollment":20},{"nctId":"NCT00846742","phase":"PHASE2","title":"Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2009-06-05","conditions":"Hodgkin Lymphoma","enrollment":88},{"nctId":"NCT07258199","phase":"NA","title":"TACE Treats Nodular Goiter","status":"ENROLLING_BY_INVITATION","sponsor":"Peking Union Medical College Hospital","startDate":"2025-09-01","conditions":"Nodular Goiter","enrollment":30},{"nctId":"NCT02341989","phase":"PHASE3","title":"Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Olavs Hospital","startDate":"2015-04-08","conditions":"Testicular Neoplasms, Seminoma","enrollment":348},{"nctId":"NCT07201766","phase":"NA","title":"The Efficacy of Intralesional Bleomycin as Compared to 5-Flourouracil (5-FU) and Triamcinolone Acetonide (TAC) for the Treatment of Keloids: A Randomized Control Trial.","status":"NOT_YET_RECRUITING","sponsor":"King Edward Medical University","startDate":"2025-12-02","conditions":"Keloids Scars","enrollment":104},{"nctId":"NCT07246928","phase":"NA","title":"US-guided Intralesional Injection of Cystic Hygroma - A Case Report","status":"COMPLETED","sponsor":"Delta University for Science and Technology","startDate":"2024-09-01","conditions":"Intralesional Injection of Cystic Hygroma","enrollment":1},{"nctId":"NCT07189832","phase":"NA","title":"Bleomycin Intralesional Injections of Cystic Hygromas","status":"COMPLETED","sponsor":"Delta University for Science and Technology","startDate":"2024-09-01","conditions":"Lymphatic Malformations","enrollment":30},{"nctId":"NCT06421987","phase":"","title":"Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-05-06","conditions":"Hodgkin Lymphoma, Adult","enrollment":100},{"nctId":"NCT07197541","phase":"PHASE4","title":"A Self-controlled Study of Bleomycin and Pingyangmycin Injection in the Treatment of Plantar Warts","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-10-01","conditions":"Plantar Wart","enrollment":200},{"nctId":"NCT06144736","phase":"PHASE2","title":"PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND","status":"RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2023-08-28","conditions":"Seminoma","enrollment":60},{"nctId":"NCT07171827","phase":"NA","title":"Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Helwan University","startDate":"2023-03-01","conditions":"Anti-CD30, Brentuximab, Doxorubicin","enrollment":60},{"nctId":"NCT02758717","phase":"PHASE2","title":"Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academic and Community Cancer Research United","startDate":"2016-05-13","conditions":"Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma","enrollment":46},{"nctId":"NCT07120217","phase":"","title":"Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.","status":"COMPLETED","sponsor":"Federico II University","startDate":"2008-01-01","conditions":"Hodgkin Disease, Breast Cancer, Liposomal Doxorubicin","enrollment":200},{"nctId":"NCT06715592","phase":"PHASE2","title":"ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-05-23","conditions":"Paget Disease of the Vulva, Vulva Cancer","enrollment":18},{"nctId":"NCT03159897","phase":"PHASE3","title":"FIL Study on ABVD DD-DI as Upfront Therapy in HL.","status":"COMPLETED","sponsor":"Fondazione Italiana Linfomi - ETS","startDate":"2017-08-01","conditions":"Hodgkin Lymphoma","enrollment":500},{"nctId":"NCT06753136","phase":"NA","title":"Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype","status":"RECRUITING","sponsor":"Istituto Oncologico Veneto IRCCS","startDate":"2025-07-23","conditions":"Primary Visceral Tumors of Any Histotype, Visceral Lesions, Liver Cancer","enrollment":24},{"nctId":"NCT00049595","phase":"PHASE3","title":"Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2002-08","conditions":"Lymphoma","enrollment":552},{"nctId":"NCT00379041","phase":"PHASE3","title":"Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1993-09-01","conditions":"Lymphoma","enrollment":1158},{"nctId":"NCT07104526","phase":"NA","title":"Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH)","status":"COMPLETED","sponsor":"Wuhan Integrated Traditional Chinese and Western Medicine Hospital","startDate":"2024-01-01","conditions":"Infantile Hemangioma (IH)","enrollment":260},{"nctId":"NCT00002462","phase":"PHASE3","title":"RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1989-09","conditions":"Lymphoma","enrollment":615},{"nctId":"NCT00005584","phase":"PHASE3","title":"Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1998-10","conditions":"Lymphoma","enrollment":1649},{"nctId":"NCT01873326","phase":"PHASE2","title":"Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2013-06","conditions":"Germ Cell Tumors","enrollment":92},{"nctId":"NCT07041749","phase":"NA","title":"Microneedling Alone Versus Microneedling Coupled With Either Bleomycin or 5flourouracil in the Treatment of Plantar Warts","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-06-01","conditions":"Warts of Foot","enrollment":60},{"nctId":"NCT02582697","phase":"PHASE3","title":"Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours","status":"RECRUITING","sponsor":"University of Sydney","startDate":"2014-02","conditions":"Germ Cell Tumor","enrollment":500},{"nctId":"NCT05008224","phase":"PHASE2","title":"Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-10-07","conditions":"Classical Hodgkin Lymphoma","enrollment":146},{"nctId":"NCT05705687","phase":"NA","title":"Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2023-05-05","conditions":"Non-Seminomatous Germ Cell Tumor","enrollment":150},{"nctId":"NCT06943703","phase":"","title":"Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma","status":"COMPLETED","sponsor":"National Children's Hospital, Vietnam","startDate":"2018-01-01","conditions":"Lymphangioma, Lymphatic Malformations","enrollment":809},{"nctId":"NCT05427136","phase":"","title":"Early Pulmonary Dysfunction in Childhood Cancer Patients","status":"RECRUITING","sponsor":"University Children's Hospital Basel","startDate":"2021-06-01","conditions":"Pulmonary Dysfunction","enrollment":140},{"nctId":"NCT06718192","phase":"PHASE1, PHASE2","title":"A Randomized Controlled Trial to Evaluate the Effectiveness of Bleomycin and Cryotherapy in Treating Plantar Warts.","status":"RECRUITING","sponsor":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","startDate":"2024-12-25","conditions":"Verruca Plantaris","enrollment":70},{"nctId":"NCT00104676","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors","status":"COMPLETED","sponsor":"UNICANCER","startDate":"2003-11-26","conditions":"Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor","enrollment":263},{"nctId":"NCT06647342","phase":"PHASE4","title":"The Effect of Reduced Bleomycin in Electrochemotherapy Treatment","status":"RECRUITING","sponsor":"Julie Gehl","startDate":"2024-10-29","conditions":"Cutaneous Metastasis, Cutaneous Malignant Mixed Tumor, Bleomycin Adverse Reaction","enrollment":55},{"nctId":"NCT06744946","phase":"PHASE4","title":"Thoracoscopic Talc Pleurodesis Versus Bleomycin -Tranxemic Acid Mixture Injection in Chest Tube in Malignant Pleural Effusion","status":"COMPLETED","sponsor":"Mohamed Sabry","startDate":"2024-09-01","conditions":"Malignant Pleural Effusions (Mpe)- Pleurodesis, Pleurodesis","enrollment":60},{"nctId":"NCT01726374","phase":"PHASE3","title":"Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours","status":"COMPLETED","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2010-02","conditions":"Stage I Testicular Non-Seminomatous Germ Cell Tumor","enrollment":246},{"nctId":"NCT06691009","phase":"NA","title":"Pleural Bleomycin vs Mechanical Abrasion in Malignant Pleural Effusion","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-12-10","conditions":"Malignant Pleural Effusion","enrollment":70},{"nctId":"NCT06683404","phase":"","title":"GISEL:Registry of Breast Cancer Patients Treated With ECT","status":"COMPLETED","sponsor":"Istituto Oncologico Veneto IRCCS","startDate":"2016-04-22","conditions":"Breast Cancer, Breast Cancer Metastatic, Breast Cancer Recurrent","enrollment":205},{"nctId":"NCT03712202","phase":"PHASE2","title":"Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2018-11-28","conditions":"Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma","enrollment":155},{"nctId":"NCT06189092","phase":"","title":"Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2023-10-28","conditions":"Vascular Malformations","enrollment":65},{"nctId":"NCT04760327","phase":"PHASE2","title":"Electrochemotherapy of Gynecological Cancers","status":"RECRUITING","sponsor":"Institute of Oncology Ljubljana","startDate":"2020-07-01","conditions":"Gynecological Cancers","enrollment":30},{"nctId":"NCT04638790","phase":"PHASE3","title":"First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)","status":"RECRUITING","sponsor":"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia","startDate":"2020-02-01","conditions":"Hodgkin Lymphoma, Adult","enrollment":300},{"nctId":"NCT03142061","phase":"NA","title":"Electrochemotherapy for the Inoperable Vulva Carcinoma","status":"COMPLETED","sponsor":"University Hospital Tuebingen","startDate":"2017-06-01","conditions":"Advanced Inoperable Vulva Carcinoma","enrollment":50},{"nctId":"NCT06510829","phase":"","title":"Comparison Between Diode Laser and Bleomycin in Treatment of Hemangioma","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-09-01","conditions":"Bleomycin Adverse Reaction","enrollment":30},{"nctId":"NCT06437158","phase":"PHASE2","title":"Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2023-03-08","conditions":"Lymphatic Malformation","enrollment":200},{"nctId":"NCT02661503","phase":"PHASE3","title":"HD21 for Advanced Stages","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cologne","startDate":"2016-07","conditions":"Classical Hodgkin Lymphoma","enrollment":1500},{"nctId":"NCT00678327","phase":"PHASE3","title":"Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma","status":"COMPLETED","sponsor":"University College, London","startDate":"2008-08-29","conditions":"Lymphoma","enrollment":1202},{"nctId":"NCT06104878","phase":"","title":"A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone","status":"WITHDRAWN","sponsor":"Takeda","startDate":"2023-12-31","conditions":"Hodgkin Lymphoma","enrollment":""},{"nctId":"NCT06263530","phase":"","title":"Prognostic Significance of ctDNA in HL","status":"RECRUITING","sponsor":"Interni hematologicka klinika FNKV","startDate":"2022-01-02","conditions":"Prognostic Cancer Model","enrollment":500},{"nctId":"NCT05916690","phase":"NA","title":"Electrochemotherapy for the Treatment of Vulvar Cancer","status":"UNKNOWN","sponsor":"Institute of Oncology Ljubljana","startDate":"2021-03-01","conditions":"Vulvar Cancer","enrollment":20},{"nctId":"NCT01858922","phase":"PHASE2","title":"Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2012-12-19","conditions":"Hodgkin Disease","enrollment":40},{"nctId":"NCT01347294","phase":"PHASE4","title":"Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations","status":"UNKNOWN","sponsor":"Oslo University Hospital","startDate":"2011-08","conditions":"Venous Malformation","enrollment":135},{"nctId":"NCT06080724","phase":"NA","title":"Efficacy of Intralesional Bleomycin Alone and in Combination With Dexamethasone in Infantile Haemangiomas","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2021-03-22","conditions":"Comparison of Efficacy of Sclerotherapy in Infantile Hemangioma","enrollment":114},{"nctId":"NCT00352027","phase":"PHASE2","title":"Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2006-07-20","conditions":"Hodgkin's Lymphoma","enrollment":81},{"nctId":"NCT05327309","phase":"NA","title":"Role of Propranolol as Compared to Bleomycin in Management of Hemangioma","status":"COMPLETED","sponsor":"Shaheed Zulfiqar Ali Bhutto Medical University","startDate":"2015-05-08","conditions":"Hemangioma, Propranolol","enrollment":90},{"nctId":"NCT00003389","phase":"PHASE3","title":"Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"1999-06-17","conditions":"Lymphoma","enrollment":854},{"nctId":"NCT01390584","phase":"PHASE2","title":"Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma","status":"TERMINATED","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2013-05-24","conditions":"Lymphoma","enrollment":6},{"nctId":"NCT00002872","phase":"PHASE3","title":"Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"1997-01-10","conditions":"Metastatic Cancer","enrollment":480},{"nctId":"NCT02429700","phase":"PHASE3","title":"TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors","status":"RECRUITING","sponsor":"Beihua Kong","startDate":"2015-04","conditions":"Ovarian Sex Cord Stromal Tumor, Ovarian Neoplasms, Ovarian Cancer","enrollment":132},{"nctId":"NCT02429687","phase":"PHASE3","title":"TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors","status":"RECRUITING","sponsor":"Beihua Kong","startDate":"2015-04","conditions":"Ovarian Germ Cell Cancer, Ovarian Neoplasms, Ovarian Cancer","enrollment":129},{"nctId":"NCT05752435","phase":"NA","title":"Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryotherapy in Plantar Warts","status":"COMPLETED","sponsor":"Combined Military Hospital Abbottabad","startDate":"2022-07-01","conditions":"Viral Wart","enrollment":102},{"nctId":"NCT05670938","phase":"","title":"Follow-up After Surgery for Testicular Cancer","status":"RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2022-11-30","conditions":"Testicular Cancer, Testicular Germ Cell Tumor, Quality of Life","enrollment":145},{"nctId":"NCT04582305","phase":"PHASE4","title":"Bleomycin Jet Injections in Keloids","status":"UNKNOWN","sponsor":"Erasmus Medical Center","startDate":"2022-03-18","conditions":"Keloid","enrollment":14},{"nctId":"NCT02104986","phase":"PHASE2","title":"A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent","status":"COMPLETED","sponsor":"Centre Leon Berard","startDate":"2014-05-12","conditions":"Extra Cranial Non Seminomateous Malignant Germ Cell Tumour","enrollment":117},{"nctId":"NCT02292979","phase":"PHASE2","title":"Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma.","status":"COMPLETED","sponsor":"The Lymphoma Academic Research Organisation","startDate":"2015-03","conditions":"Hodgkin Lymphoma","enrollment":170},{"nctId":"NCT00822120","phase":"PHASE2","title":"S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2009-07","conditions":"Lymphoma, Nonneoplastic Condition","enrollment":371},{"nctId":"NCT05494710","phase":"NA","title":"Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study","status":"UNKNOWN","sponsor":"South Tees Hospitals NHS Foundation Trust","startDate":"2020-12-01","conditions":"Vascular Malformations","enrollment":20},{"nctId":"NCT04649372","phase":"NA","title":"EndoVE endosCopic Treatment for Oesophageal and Gastric canceR","status":"COMPLETED","sponsor":"Mirai Medical","startDate":"2021-01-13","conditions":"Oesophageal Cancer, Oesophageal Disease, Gastric Cancer","enrollment":30},{"nctId":"NCT05395962","phase":"PHASE2","title":"Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2022-04-08","conditions":"Vulvar Cancer","enrollment":92},{"nctId":"NCT05362253","phase":"NA","title":"Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial","status":"COMPLETED","sponsor":"Yifeng Yu","startDate":"2021-03-01","conditions":"Recurrent Pterygium, Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation","enrollment":40},{"nctId":"NCT01026220","phase":"PHASE3","title":"Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2009-12-07","conditions":"Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma","enrollment":166},{"nctId":"NCT00198315","phase":"PHASE3","title":"Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma","status":"TERMINATED","sponsor":"Inovio Pharmaceuticals","startDate":"2004-06","conditions":"Head and Neck Cancer","enrollment":130},{"nctId":"NCT00198328","phase":"PHASE3","title":"Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma","status":"TERMINATED","sponsor":"Inovio Pharmaceuticals","startDate":"2004-11","conditions":"Head Neck Cancer","enrollment":84},{"nctId":"NCT01606566","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.","status":"TERMINATED","sponsor":"PCI Biotech AS","startDate":"2012-04","conditions":"Recurrent Head and Neck Cancer, Carcinoma, Squamous Cell of Head and Neck","enrollment":26},{"nctId":"NCT01042522","phase":"PHASE2","title":"Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors","status":"UNKNOWN","sponsor":"GOG Foundation","startDate":"2010-02-08","conditions":"Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor","enrollment":63},{"nctId":"NCT01578967","phase":"NA","title":"Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2012-04","conditions":"Hodgkin Lymphoma, Adult","enrollment":41},{"nctId":"NCT01118026","phase":"PHASE2","title":"Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2010-09","conditions":"Lymphoma","enrollment":101},{"nctId":"NCT00000987","phase":"PHASE1","title":"A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Sarcoma, Kaposi, HIV Infections","enrollment":36},{"nctId":"NCT00000681","phase":"PHASE1","title":"A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Sarcoma, Kaposi, HIV Infections","enrollment":24},{"nctId":"NCT00000658","phase":"PHASE3","title":"A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Lymphoma, Non-Hodgkin, HIV Infections","enrollment":250},{"nctId":"NCT00000703","phase":"NA","title":"Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Lymphoma, Non-Hodgkin, HIV Infections","enrollment":45},{"nctId":"NCT00000689","phase":"PHASE1","title":"Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Lymphoma, Non-Hodgkin, HIV Infections","enrollment":18},{"nctId":"NCT00000954","phase":"PHASE1","title":"A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Sarcoma, Kaposi, HIV Infections","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2899,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Blenoxane","BLM"],"phase":"phase_3","status":"active","brandName":"Bleomycin Sulfate (BLM)","genericName":"Bleomycin Sulfate (BLM)","companyName":"M.D. Anderson Cancer Center","companyId":"m-d-anderson-cancer-center","modality":"Biologic","firstApprovalDate":"","aiSummary":"Bleomycin is a chemotherapeutic antibiotic that binds to DNA and causes strand breaks, leading to cell death. Used for Hodgkin lymphoma, Non-Hodgkin lymphoma, Testicular cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}